checkAd

Exela Technologies Announces Strategic Investment in UBERDOC, a Leading Patient Access and Price Transparency Platform

IRVING, Texas, March 25, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA), a global business process automation (BPA) leader, announced today a strategic investment in UBERDOC, Inc. UBERDOC is a leading patient access and price transparency platform connecting patients to top doctors for in-person and telemedicine appointments. UBERDOC plans to use the proceeds from this investment to scale its offering to patients nationwide, advancing UBERDOC’s mission to provide faster, more affordable care by creating an open, transparent marketplace where patients can connect directly to the doctors they need.

UBERDOC is currently the largest network of direct-pay specialists in the country and has partnerships with employers, medical cost sharing plans, government agencies, and accountable care organizations. The platform currently hosts over 4,000 active specialists and primary care doctors, covering nearly 50 states and offering over 15,000 available appointments each week. UBERDOC’s expanding platform also offers users affordable prices for home delivery prescriptions, bloodwork, and imaging.

“You shouldn’t have to have the right insurance, the right employer, or know the right person to receive the best care,” said Dr. Paula Muto, a practicing surgeon, Founder and CEO of UBERDOC. “Everyone deserves equal access to the healthcare they need when they need it. With UBERDOC, every patient can make an appointment without a phone call or referral, at a price lower than that of commercial insurance.”

Exela’s strategic investment in UBERDOC pairs the largest direct-pay specialist network with Exela’s leading digital healthcare footprint along with its exchange for bills and payments (XBP), and HCM benefits administration platform, furthering the network effect of both companies. UBERDOC users, in addition to benefiting from priority access to leading specialist with fixed price transparency, will be able to seamlessly submit eligible direct-pay costs to their insurance plan for reimbursement and/or application towards their deductible. UBERDOC’s 4,000 active specialists will have plug & play access to Exela revenue cycle management solutions and can leverage a suite of digital transformation and intelligent automation solutions across all billing models.

Seite 1 von 3



0 Kommentare
Nachrichtenquelle: globenewswire
 |  198   |   |   

Schreibe Deinen Kommentar

Disclaimer

Exela Technologies Announces Strategic Investment in UBERDOC, a Leading Patient Access and Price Transparency Platform IRVING, Texas, March 25, 2022 (GLOBE NEWSWIRE) - Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA), a global business process automation (BPA) leader, announced today a strategic investment in UBERDOC, Inc. UBERDOC is a leading …

Nachrichten des Autors

213 Leser
192 Leser
169 Leser
168 Leser
165 Leser
163 Leser
162 Leser
155 Leser
153 Leser
152 Leser
1078 Leser
377 Leser
366 Leser
358 Leser
344 Leser
325 Leser
300 Leser
291 Leser
290 Leser
278 Leser
1624 Leser
1291 Leser
1078 Leser
700 Leser
677 Leser
661 Leser
625 Leser
614 Leser
604 Leser
602 Leser
10065 Leser
3944 Leser
3060 Leser
2744 Leser
2190 Leser
2143 Leser
2045 Leser
1624 Leser
1603 Leser
1602 Leser